Biohit Oyj (HEL:BIOBV)

Market Cap	46.61M
Revenue (ttm)	14.30M
Net Income (ttm)	2.60M
Shares Out	15.18M
EPS (ttm)	0.17
PE Ratio	18.06
Forward PE	20.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,415
Average Volume	17,077
Open	2.870
Previous Close	2.880
Day's Range	2.850 - 3.070
52-Week Range	1.865 - 4.350
Beta	0.89
RSI	52.70
Earnings Date	Feb 12, 2025

About Biohit Oyj

Biohit Oyj, a biotechnology company, manufactures and sells bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry worldwide. The company’s diagnostic tests product includes the GastroPanel Unified test panel for stomach health check; GastroPanel Four-in-One stomach test; GastroSoft software application to assist clinicians and general practitioner; Biohit Active B12, a test for measuring the levels of active vitamin B12; BIOHIT Total 25OH Vitamin D, a test for ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Employees: 46
• Stock Exchange: Nasdaq Helsinki
• Ticker Symbol: BIOBV

Financial Performance

In 2024, Biohit Oyj's revenue was 14.30 million, an increase of 9.36% compared to the previous year's 13.08 million. Earnings were 2.60 million, an increase of 40.46%.